BR112013022431B1 - Derivado de polissacarídeo, forma de dosagem, processo para preparar uma forma de dosagem e uso de um derivado de polissacarídeo - Google Patents

Derivado de polissacarídeo, forma de dosagem, processo para preparar uma forma de dosagem e uso de um derivado de polissacarídeo Download PDF

Info

Publication number
BR112013022431B1
BR112013022431B1 BR112013022431-2A BR112013022431A BR112013022431B1 BR 112013022431 B1 BR112013022431 B1 BR 112013022431B1 BR 112013022431 A BR112013022431 A BR 112013022431A BR 112013022431 B1 BR112013022431 B1 BR 112013022431B1
Authority
BR
Brazil
Prior art keywords
particles
polysaccharide derivative
polysaccharide
dosage form
percent
Prior art date
Application number
BR112013022431-2A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112013022431A2 (pt
Inventor
Jennifer L'hote-Gaston
Nicholas S. Grasman
Jorg Theuerkauf
Sjoerd A. de Vries
Original Assignee
Dow Global Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45953271&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013022431(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dow Global Technologies Llc filed Critical Dow Global Technologies Llc
Publication of BR112013022431A2 publication Critical patent/BR112013022431A2/pt
Publication of BR112013022431B1 publication Critical patent/BR112013022431B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BR112013022431-2A 2011-04-06 2012-03-29 Derivado de polissacarídeo, forma de dosagem, processo para preparar uma forma de dosagem e uso de um derivado de polissacarídeo BR112013022431B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161472224P 2011-04-06 2011-04-06
US61/472,224 2011-04-06
PCT/US2012/031106 WO2012138529A1 (en) 2011-04-06 2012-03-29 Novel polysaccharide derivatives and dosage forms

Publications (2)

Publication Number Publication Date
BR112013022431A2 BR112013022431A2 (pt) 2016-12-06
BR112013022431B1 true BR112013022431B1 (pt) 2019-10-08

Family

ID=45953271

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013022431-2A BR112013022431B1 (pt) 2011-04-06 2012-03-29 Derivado de polissacarídeo, forma de dosagem, processo para preparar uma forma de dosagem e uso de um derivado de polissacarídeo

Country Status (8)

Country Link
US (1) US8992987B2 (ja)
EP (1) EP2694110B2 (ja)
JP (1) JP5731708B2 (ja)
KR (1) KR101916010B1 (ja)
CN (1) CN103501817B (ja)
BR (1) BR112013022431B1 (ja)
MX (1) MX337827B (ja)
WO (1) WO2012138529A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5731708B2 (ja) 2011-04-06 2015-06-10 ダウ グローバル テクノロジーズ エルエルシー 新規多糖類誘導体及び剤形
WO2014052217A1 (en) * 2012-09-27 2014-04-03 Dow Global Technologies Llc Methods for reducing oil and / or fat uptake of fried foods
EP2989902B1 (en) * 2012-09-27 2017-11-01 Dow Global Technologies LLC Methods for reducing oil and/or fat uptake of fried foods
US10188129B2 (en) 2012-09-27 2019-01-29 Dow Global Technologies Llc Methods for reducing oil and/or fat uptake of fried foods
EP2837391B1 (en) 2013-08-12 2017-05-10 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate
JP2016122227A (ja) * 2014-12-24 2016-07-07 株式会社東芝 メモリシステムおよび情報処理システム
KR102469464B1 (ko) * 2016-10-07 2022-11-22 신에쓰 가가꾸 고교 가부시끼가이샤 저치환도 히드록시프로필 셀룰로오스 및 그의 제조 방법, 및 고형 제제
KR102519850B1 (ko) 2016-10-07 2023-04-10 신에쓰 가가꾸 고교 가부시끼가이샤 히드록시알킬 알킬 셀룰로오스 및 그의 제조 방법, 및 고형 제제
KR102519854B1 (ko) 2016-10-07 2023-04-10 신에쓰 가가꾸 고교 가부시끼가이샤 히드록시알킬 알킬 셀룰로오스 및 그의 제조 방법, 및 고형 제제

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB804306A (en) 1956-12-13 1958-11-12 Dow Chemical Co Method of preparing cellulose ethers readily soluble in cold water
DE2620461A1 (de) 1976-05-08 1977-11-24 Kloeckner Humboldt Deutz Ag Mahltrocknungsanlage
AU508480B2 (en) * 1977-04-13 1980-03-20 Asahi Kasei Kogyo Kabushiki Kaisha Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
JPS5420126A (en) * 1977-07-12 1979-02-15 Asahi Chem Ind Co Ltd Pharmaceutical composition
JPS53127553A (en) * 1977-04-13 1978-11-07 Asahi Chem Ind Co Ltd Vehicle
US4650716A (en) 1985-05-14 1987-03-17 Hercules Incorporated Novel salts of carboxymethylcellulose
US4734285A (en) 1985-10-28 1988-03-29 The Dow Chemical Company Sustained release compositions
DE3839831A1 (de) 1988-11-25 1990-05-31 Hoechst Ag Verfahren und vorrichtung zur produktschonenden mahlung und gleichzeitigen trocknung von feuchten celluloseethern
CA2071488C (en) † 1990-08-24 1996-05-07 Kazuto Kobayashi Base for film-coating pharmaceuticals and method for preparing same
DE4140689B4 (de) 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB2262527A (en) 1992-07-02 1993-06-23 Dow Deutschland Inc Process for grinding cellulose compounds
JP2686215B2 (ja) † 1993-04-28 1997-12-08 信越化学工業株式会社 徐放性錠剤
US5488104A (en) * 1994-06-30 1996-01-30 The Dow Chemical Company Process for comminuting cellulose ethers
US5585115A (en) 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
EP0824107A3 (de) 1996-08-12 1998-04-22 Lenzing Aktiengesellschaft Cellulosepartikel
EP0954536B2 (de) 1997-01-21 2009-01-07 Dow Wolff Cellulosics GmbH Verfahren zur herstellung von feinteiligen polysaccharidderivaten
GB9802201D0 (en) 1998-02-03 1998-04-01 Cerestar Holding Bv Free-flowable directly compressible starch as binder,disintegrant and filler for compresion tablets and hard gelatine capsules
DE10009409A1 (de) † 2000-02-28 2001-08-30 Wolff Walsrode Ag Verfahren zur Herstellung von pulverförmigen wasserlöslichen Cellulosederivaten
DE10009411A1 (de) † 2000-02-28 2001-08-30 Wolff Walsrode Ag Verfahren zur Herstellung pulverförmiger wasserlöslicher Cellulosederivate unter Einsatz eines Wasserdampf/Inertgas-Gemisch oder Wasserdampf/Luft-Gemisch als Transport und Wärmeträgergas
ES2739023T3 (es) 2001-07-06 2020-01-28 Veloxis Pharmaceuticals As Aglomeración controlada
AU2005237523A1 (en) 2004-04-23 2005-11-10 Cydex Pharmaceuticals, Inc. DPI formulation containing sulfoalkyl ether cyclodextrin
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
DK2952197T3 (en) * 2005-10-26 2017-08-07 Cydex Pharmaceuticals Inc SULPHALYCYLETER CYCLE CODE EXTRACTION COMPOSITION AND PROCEDURE FOR PREPARING THEREOF
JP5612462B2 (ja) * 2007-04-13 2014-10-22 ダウ グローバル テクノロジーズ エルエルシー 剤形用の粒状物質
US20100273873A1 (en) 2007-07-31 2010-10-28 Katleen Rosa Francois Brys Direct compressible dextrose
WO2010106555A2 (en) 2009-03-17 2010-09-23 Shantilal, Doshi, Bimalkumar Directly compressible pre-granulated cellulose ether polymer and process for preparing the same
TWI400089B (zh) * 2009-11-24 2013-07-01 Nippon Soda Co 羥烷基纖維素微粒子
EP2598557B1 (en) 2010-07-28 2019-03-20 Dow Global Technologies LLC A process for dry-grinding a polysaccharide derivative
JP5866358B2 (ja) 2010-07-28 2016-02-17 ダウ グローバル テクノロジーズ エルエルシー 剤形からの活性含有成分の放出の制御方法
JP5731708B2 (ja) 2011-04-06 2015-06-10 ダウ グローバル テクノロジーズ エルエルシー 新規多糖類誘導体及び剤形
MX343509B (es) * 2011-04-06 2016-11-08 Dow Global Technologies Llc Proceso para producir derivados de celulosa de alta densidad aparente y buena fluidez.
BR112013022418A2 (pt) * 2011-04-06 2016-12-06 Dow Global Technologies Llc processo para produzir um derivado de celulose particulado, derivado de celulose particulado, método para melhorar a fluidez e a facilidade de dispersão em água fria de um derivado de celulose particulado, composição aquosa, processo para a fabricação de cápsulas e processo para revestir uma forma de dosagem

Also Published As

Publication number Publication date
US8992987B2 (en) 2015-03-31
EP2694110A1 (en) 2014-02-12
JP2014510137A (ja) 2014-04-24
EP2694110B2 (en) 2022-06-08
JP5731708B2 (ja) 2015-06-10
WO2012138529A1 (en) 2012-10-11
CN103501817A (zh) 2014-01-08
MX2013011586A (es) 2013-12-09
KR101916010B1 (ko) 2018-11-08
EP2694110B1 (en) 2015-02-11
KR20140009452A (ko) 2014-01-22
MX337827B (es) 2016-03-22
US20140017326A1 (en) 2014-01-16
BR112013022431A2 (pt) 2016-12-06
CN103501817B (zh) 2015-07-15

Similar Documents

Publication Publication Date Title
BR112013022431B1 (pt) Derivado de polissacarídeo, forma de dosagem, processo para preparar uma forma de dosagem e uso de um derivado de polissacarídeo
KR101960244B1 (ko) 높은 벌크 밀도 및 양호한 유동성의 셀룰로스 유도체를 제조하는 방법
US9655851B2 (en) Granular material for dosage forms
US9616036B2 (en) Sustained release dosage forms
JP2015515522A (ja) セルロースエーテルを含む溶融押出し組成物
US9693960B2 (en) Method of controlling the release of an active ingredient from a dosage form

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/03/2012, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/03/2012, OBSERVADAS AS CONDICOES LEGAIS

B25A Requested transfer of rights approved

Owner name: THE DOW CHEMICAL COMPANY (US)

B25A Requested transfer of rights approved

Owner name: DDP SPECIALTY ELECTRONIC MATERIALS US, INC. (US)

B25D Requested change of name of applicant approved

Owner name: DDP SPECIALTY ELECTRONIC MATERIALS US, LLC (US)

B25A Requested transfer of rights approved

Owner name: NUTRITION AND BIOSCIENCES USA 1, LLC (US)